Skip to main content

Lee Sung

In the past year, 5 open-market sale filings worth $5.70M and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$5.70M
5 filings
Net
−$5.70M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Lee Sung as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

CYTK Cytokinetics Inc

EVP, Chief Financial Officer5 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 2, 2026 (view filing)5:17 PM ETJul 11 dayLee SungEVP, Chief Financial OfficerSSale−1.11K$87.79−$97.6K−1.7%63.2K after10b5-1
Jun 29, 2026 (view filing)Jun 245 daysLateLee SungEVP, Chief Financial OfficerSSale−38.7K$82.30−$3.19M−38.0%63.2K after10b5-1
Jun 29, 2026 (view filing)Jun 29Same dayLee SungEVP, Chief Financial OfficerSSale−3.13K$85.00−$266.4K−4.7%63.2K after10b5-1
May 5, 2026 (view filing)May 5Same dayLee SungEVP, Chief Financial OfficerSSale−23.9K$76.87−$1.84M−27.4%63.2K after10b5-1
Mar 18, 2026 (view filing)Mar 171 dayLee SungEVP, Chief Financial OfficerSSale−4.93K$62.15−$306.7K−5.4%87.1K after

VIR Vir Biotechnology, Inc.

EVP & Chief Financial Officer1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 28, 2024 (view filing)Mar 271 dayLee SungEVP & Chief Financial OfficerSSale−6.01K$9.89−$59.4K−5.6%100.5K after